US Map / Utah
State UT

Clinical Trials in Utah

Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 211 actively recruiting studies with Utah sites out of 211 registered in total. The busiest research areas in Utah are Breast Cancer, Prostate Cancer, Ovarian Cancer. Leading sponsors running trials in the state include University of Utah, National Cancer Institute (NCI), Eli Lilly and Company. By stage, Utah trials break down as Phase 1 (42), Phase 2 (65), Phase 3 (71), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
211
Recruiting Now
211
← Back to US Map
Top Conditions in Utah
Breast Cancer (9)Prostate Cancer (6)Ovarian Cancer (5)Solid Tumor (5)Endometrial Cancer (3)Cervical Cancer (3)Advanced Solid Tumor (3)Solid Tumor, Adult (3)Acute Myeloid Leukemia (3)Obesity (3)Overweight (3)Advanced Solid Tumors (3)

Frequently Asked Questions — Clinical Trials in Utah

How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 211 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 211. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Utah

NCT06305312 N/A
Recruiting
Community Services Navigation to Advance Health Equity in Breast Cancer Screenin...
Condition
Breast Cancer
Enrollment
1,450 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT06797336 Phase 1
Recruiting
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
300 pts
Location
United States, South Korea
Sponsor
PAQ Therapeutics, Inc.
View Trial →
NCT06971939 Phase 4
Recruiting
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Includi...
Condition
Macular Telangiectasia Type 2 (MacTel)
Enrollment
234 pts
Location
United States, Australia
Sponsor
Neurotech Pharmaceuticals
View Trial →
NCT05896839 Phase 1, Phase 2
Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
16 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05611801 Phase 3
Recruiting
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemo...
Condition
Hemophilia A
Enrollment
100 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06548542 Phase 2
Recruiting
Study of Targeted Therapies for the Treatment of Adult Participants With Moderat...
Condition
Crohn's Disease
Enrollment
590 pts
Location
United States, Austria, Belgium
Sponsor
AbbVie
View Trial →
NCT07570654 Phase 2, Phase 3
Recruiting
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COM...
Condition
PTSD - Post Traumatic Stress Disorder
Enrollment
300 pts
Location
United States, Canada
Sponsor
COMPASS Pathways
View Trial →
NCT07584434 Phase 1
Recruiting
A Phase 1, First-in-human Study of VX-433
Condition
Narcolepsy Type 1 (NT1)
Enrollment
118 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07151391 Phase 2
Recruiting
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and G...
Condition
Neuroendocrine Tumors
Enrollment
86 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT07029490 N/A
Recruiting
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources ...
Condition
Breast Cancer
Enrollment
2,700 pts
Location
United States
Sponsor
University of Utah
View Trial →
Page 9 of 9 — 211 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology